{"product_id":"demant-five-forces-analysis","title":"Demant Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDon't Miss the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDemant's Porter's Five Forces snapshot highlights supplier concentration, moderate buyer power, technological substitution risks, regulatory barriers, and rivalry intensity shaping margins and growth prospects. This brief overview surfaces strategic pressures but omits force-by-force ratings and visuals. Unlock the full Porter's Five Forces Analysis to explore Demant’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier Power 1\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSpecialized components like miniaturized microphones, DSP\/ASICs and rechargeable batteries narrow the qualified supplier pool, increasing pricing power and lead times; Demant mitigates this with multi-sourcing where feasible, but supplier requalification is costly and can take several months, and stringent regulatory quality and medical device requirements further constrain alternative suppliers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier Power 2\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFoundry capacity for custom chips and Bluetooth modules can be tight during cycles, with major foundries running near 90% utilization in 2024. Suppliers exposed to consumer electronics demand often prioritize larger-volume clients, shifting allocations toward top OEMs. Long-term agreements help secure allocations but can lock in pricing. High forecast accuracy is therefore critical to preserve bargaining leverage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier Power 3\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMaterials and precision plastics are largely commoditized, moderating supplier power, while ultra-precision tooling and medical-grade polymers still require vetted partners and specialized contracts. Switching costs persist due to tooling, validation and compliance documentation, raising barriers despite commodity inputs. Demant’s scale—reported revenue of DKK 17.0bn in 2024—gives purchasing leverage that helps counterbalance vendor influence in negotiations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier Power 4\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSupplier Power 4: Software and firmware stacks (wireless protocols, SDKs) create vendor dependencies that directly shape feature timing; in 2024 the global medical device software market surpassed USD 30bn, intensifying supplier leverage. API\/SDK roadmaps and support SLAs become key negotiation levers; proprietary integration lowers but does not remove reliance on external tech roadmaps.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNegotiation focus: access, SLAs, roadmap visibility\u003c\/li\u003e\n\u003cli\u003eCost impact: SDK\/licensing affects TTM and margins\u003c\/li\u003e\n\u003cli\u003eMitigation: selective proprietary integration, multi-vendor strategy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier Power 5\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSupplier Power 5: Global logistics and sterilized‑packaging vendors can drive costs and service levels; Demant faced elevated freight and packaging pressure in 2024 as global logistics volatility persisted. Disruptions, such as constrained alternative lanes, amplify supplier leverage and can delay shipments beyond contracted SLAs. Dual logistics partners and regional hubs reduce dependency, while selective inventory buffers balance resilience against higher working‑capital needs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 logistics volatility increased supplier leverage\u003c\/li\u003e\n\u003cli\u003eDual partners + regional hubs mitigate single‑lane risk\u003c\/li\u003e\n\u003cli\u003eSelective inventory buffers trade capex\/working capital for resilience\u003c\/li\u003e\n\u003cli\u003eSterilized packaging vendors materially influence COGS and SLAs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized suppliers tighten allocations; foundry utilization \u003cstrong\u003e~90%\u003c\/strong\u003e, revenue \u003cstrong\u003eDKK 17.0bn\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpecialized components and software suppliers exert moderate-to-high power due to limited qualified sources, regulatory requalification costs and SDK lock‑in; foundry utilization ~90% in 2024 tightened allocations. Commodity plastics moderate power, but tooling, medical polymers and sterilized packaging raise switching costs. Demant scale (revenue DKK 17.0bn in 2024) and multi‑sourcing reduce but do not eliminate supplier leverage.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eDKK 17.0bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFoundry utilization\u003c\/td\u003e\n\u003ctd\u003e~90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMed device SW market\u003c\/td\u003e\n\u003ctd\u003e\u0026gt; USD 30bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003eElevated volatility\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eUncovers key drivers of competition, customer influence, supplier power, substitutes, and entry barriers specifically for Demant, highlighting disruptive threats, pricing pressures, and strategic advantages that shape its profitability and market positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, one-sheet Porter's Five Forces for Demant that clarifies competitive pressures, highlights supplier\/customer leverage and substitute risks, and provides a ready-to-use spider chart for quick strategic decisions and slide-ready reporting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer Power 1\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHealthcare systems, insurers and large clinic chains secure volume discounts through centralized purchasing, with public procurement representing roughly 14% of EU GDP, amplifying price leverage. Tender-based procurement standardizes specs and pushes prices lower, while awards increasingly hinge on outcome data and total cost of care. Losing a major tender can shift significant market share almost overnight.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer Power 2\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIndependent audiologists prioritize reliability, fitting software and service support, and in 2024 these factors kept switching limited due to retraining and ecosystem migration costs; loyalty programs and bundled diagnostics reduce churn, while competitive trialing continues to pressure pricing and innovation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer Power 3\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnd-users are increasingly price-aware as OTC hearing aids have been permitted in the US since Oct 17, 2022, and by 2024 that policy has driven greater online transparency and direct-to-consumer options.\u003c\/p\u003e\n\u003cp\u003eFinancing and reimbursement remain key determinants of willingness to pay, with public and private coverage varying widely across markets in 2024.\u003c\/p\u003e\n\u003cp\u003eFeature differentiation in comfort, speech-in-noise performance and connectivity allows Demant to justify premiums for advanced models.\u003c\/p\u003e\n\u003cp\u003eExtended trial periods and generous return policies in 2024 continue to enhance buyer leverage, pressuring margins on entry-level products.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer Power 4\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eInstitutional buyers demand compliance, data security and clinical-workflow integration, raising vendor qualification hurdles but increasing switching costs and lock-in; service-level agreements become key negotiation levers while multi-year contracts often trade price for revenue stability.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCompliance: regulatory audits, HIT integration required\u003c\/li\u003e\n\u003cli\u003eSLA: uptime\/response-time as negotiation levers\u003c\/li\u003e\n\u003cli\u003eContracts: multi-year deals increase customer lifetime value\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer Power 5\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn implants surgeon preference and documented clinical outcomes dominate purchasing decisions, while hospital value analyses increasingly drive price pressure; 10-year revision rates for hip\/knee implants remain around 5–10%, embedding long follow-up and switching frictions. Manufacturers use evidence generation and surgeon training programs to blunt buyer power and preserve pricing. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSurgeon preference strong\u003c\/li\u003e\n\u003cli\u003eHospital value analyses → price pressure\u003c\/li\u003e\n\u003cli\u003e10–10-year implant revision rates 5–10% (switching friction)\u003c\/li\u003e\n\u003cli\u003eClinical evidence \u0026amp; training reduce buyer power\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer leverage: public procurement \u003cstrong\u003e≈14%\u003c\/strong\u003e EU GDP; surgeons, OTC squeeze\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuyers wield strong leverage: public procurement (~14% of EU GDP) and tendering push prices down; clinicians and hospitals drive value-based purchasing while surgeon preference and 10-year implant revision rates (~5–10%) create switching frictions. OTC hearing aid policy (US Oct 17, 2022) raised direct-to-consumer pressure; extended trials and generous returns squeeze entry-level margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eLeverage\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic\/Institutional\u003c\/td\u003e\n\u003ctd\u003eTenders, scale\u003c\/td\u003e\n\u003ctd\u003ePublic procurement ≈14% EU GDP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinicians\/Surgeons\u003c\/td\u003e\n\u003ctd\u003ePreference, outcomes\u003c\/td\u003e\n\u003ctd\u003eImplant revision 10yr 5–10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnd-users\u003c\/td\u003e\n\u003ctd\u003eOTC, trials\u003c\/td\u003e\n\u003ctd\u003eUS OTC permitted since 17‑Oct‑2022\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eDemant Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Demant Porter’s Five Forces analysis you'll receive immediately after purchase—no placeholders or mockups. It is the final, professionally formatted document ready for download and use. Buy once and get instant access to this same complete file.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162933637497,"sku":"demant-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/demant-five-forces-analysis.png?v=1762711456","url":"https:\/\/portersfiveforce.com\/products\/demant-five-forces-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}